Beyond cellular recognition, the complex interplay among ferroptosis regulatory mechanisms, the immunosuppressive tumor microenvironment, and resistance to immunotherapy represents another critical frontier requiring more profound elucidation
On the other hand, EXAMINE study showed that T2D patients, who had had a recent acute coronary syndrome, the rates of major adverse cardiovascular events were not increased with the DPP-4 inhibitor alogliptin as compared with placebo [28]
Cigna Cigna implemented its own set of restrictions, tightening prior authorization requirements and adding step therapy protocols that required patients to try and fail other weight management approaches before qualifying for GLP-1 coverage
doi:10.1530/EC-21-0130 12
The observation that GIPR agonism and antagonism both produce superior outcomes when combined with GLP-1R agonism remains mechanistically unresolved and represents a genuine open question in the field